Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5886949 | Journal of Critical Care | 2012 | 8 Pages |
Abstract
The PIRO, APACHE II, and MEDS have variable abilities to early discriminate and estimate in-hospital mortality of patients presenting to the ED meeting criteria for early goal-directed therapy and the severe sepsis resuscitation bundle. The PIRO may provide additional risk stratification in patients with APACHE II 25 or more. More studies are required to evaluate the clinical applicability of PIRO in high-risk patients with severe sepsis and septic shock.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
H. Bryant MD, MS, Chad MD, MPH, Michael MPH, Jim PhD, MPH, Stephen W. MD, PhD,